An interventional study of DynaMeshVisible and DynaMeshCICAT in Umbilical Hernia, sponsored by Wuerzburg University Hospital. Completed at 1 site in Germany. Open to participants aged 18 Years to 76 Years. Per ClinicalTrials.gov, last updated 2019-01-17.
Sponsored by Wuerzburg University Hospital · Not applicable, Interventional, and Treatment
The purpose of this study is to determine the exact position of a mesh which is placed in underlay position in umbilical hernia in vitro. The investigators want to gain information if the mesh lays directly next to the abdominal wall fascia or if there´s fat tissue between mesh and fascia. Furthermore they hope to get some information about the tissue incorporation.
The literature tells to supply umbilical hernia with a mesh, that overlaps 5-6 cm in each direction. To achieve this overlap an extensive taxidermy is necessary, which causes a big operation trauma. An umbilical hernia is an extended physiological stoma and compared to an incisional hernia has no risk to rip further. Therefore the researchers act on the assumption that this generous overlap is not necessary. For a short time there is a new mesh available, which combines all the necessary requirements as elasticity, effective porousness and a structure of monofilaments with MRI visibility. In a randomised clinical trial two sorts of meshes, a conventional PVDF(polyvinylidene fluoride) mesh (DynaMesh-CICAT) and a MRI visible PVDF(polyvinylidene fluoride) mesh (DynaMeshVisible) shall be compared.The investigators postulate that there is no difference between the two groups concerning complications, relapse and life quality after 4 weeks and 12 months. Altogether the goal of the study is to determine the exact position of the mesh in vitro.
The study design is a double-blinded, multicentric randomised controlled study. The radiologist and the examiner are blinded. It will be reported according to the CONSORT Statements.
The eligibility criteria is written anywhere else. The operation results after an single shot antibiotics in open method. The access happens via a semicircular infraumbilical cut. There will be prepared until the linea alba and the umbilical hernia orifice to display the hernia gap and the hernia sac. If there´s only a fat prolapse, it will be removed by ligation. If there´s an peritoneal hernia sac, the content will be repositioned and the hernia sac will be removed. The preperitoneal space will be prepared bluntly and the peritoneum will be released from the rectus sheath. A 4-6 cm trimmed mesh with a central thread will be inserted in underlay position. The central thread is used for orientation. The hernial gap will be closed in transversal direction with absorbable threads. After the reinsertion of the navel the region of the operation will be closed with subcutaneous und intracutaneous seams.
The randomisation succeeded via block randomisation at a ratio of 1 to 1. A randomisation list with SAS®-Makros "Randomisation Tables" by M. Stout is already created. There is one list for Wuerzburg and one for Kitzingen. In total there are 72 assignments created, instead of 50. But upon consultation the recruitment will be stopped after the 50th patient. According to the calculations of the epidemiological departement of the University of Wuerzburg there are 22 patients needed in each arm, that means 44 patients in total to reach the confidence interval. The patient data will be imported to EuraHS. This data entry is based on the ethics committee vote of the medical departement of Wuerzburg dated the 31th of july 2012 (application number 256/11) and the renewal of the 21st of july 2015.
If there´s an increased complication rate in one of the groups or the morphology of the MRI-visible meshes is found unsatisfactory the study will be cancelled.
The patient data will be recorded via pseudonyms.
70 studies on the registry are indexed under Hernia, Umbilical; 14 are open to participants now.
This study's enrollment of 31 is below the median of 66 across 42 interventional studies indexed under Hernia, Umbilical.
Browse Hernia, Umbilical studies →Wuerzburg University Hospital is the lead sponsor of 98 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
the umbilical hernia will be fixed with a mesh, which is incorporated with Fe3O4 particles to become visible in MRI
Device: DynaMeshVisible
the umbilical hernia will be fixed with a Non-MRI-visible PVDF Mesh
Device: DynaMeshCICAT
The umbilical hernias will be fixed with a mesh. In this group a MRI-visible mesh will be used.
The umbilical hernias will be fixed with a mesh. In this group a non-visible mesh will be used.
MRI visibility and visible size of the mesh 4 weeks after operation
A MRI will be done 4 weeks after the operation and it will be registered if the mesh is visible; furthermore there will be done some measurements to specify the exact position and the visible size of the mesh
Time frame: 4 weeks
MRI visibility and visible size of the mesh 12 months after operation
A MRI will be done 12 months after the operation and it will be registered if the mesh is visible; furthermore there will be done some measurements to specify the exact position and the visible size of the mesh
Time frame: 12 months
intraoperative and postoperative complications (30-day morbidity)
There will be registered if there are any intraoperative or postoperative complications
Time frame: 4 weeks
relapse 12 months after operation
There will be registered if there is an relapse 12 months after operation.
Time frame: 12 months
life quality 4 weeks and 12 months after operation
There will be done a questionnaire 4 weeks and 12 months after operation.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2016 to primary completion in Jul 2017, 9 months.
Of 18 interventional studies with no phase under Hernia, Umbilical, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 47. This study's 9 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wuerzburg University Hospital